Robert Michael Floyd

Insider Reports History

Location
Hanover, MD
Signature
/s/ Michael Floyd by Michael B. Kirwan, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Michael Floyd:

Form 4 holding Chief Operating Officer

Processa Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
89,794
Estimated value
$26,938
Report date
09 Feb 2023
Price
$0.3000
Ownership
by Elion Oncology, Inc.

Insider Reports Filed by Robert Michael Floyd

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .